Nurix Therapeutics Stock Forecast

Stock Price Forecast

According to 14 professional analysts, the 12-month price target for Nurix Therapeutics stock ranges from a low of $15 to a high of $35. The average analyst price target of $26.5 forecasts a 46.49% increase in the stock price over the next year.

Price Target: $26.50 (+46.49%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$26.5	$28	$35
Change	-17.08%	+46.49%	+54.78%	+93.48%

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	7	7	7	7	5	6
Buy	8	7	7	7	7	6
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	16	16	16	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza Truist Securities	Truist Securities	Strong Buy Initiates $23 → $30	Strong Buy	Initiates	$23 → $30	+65.84%	Nov 24, 2025
Gil Blum Needham	Needham	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+43.73%	Nov 4, 2025
Jeet Mukherjee BTIG	BTIG	Strong Buy Reiterates $27	Strong Buy	Reiterates	$27	+49.25%	Nov 4, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $33 → $28	Strong Buy	Maintains	$33 → $28	+54.78%	Oct 27, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $22 → $21	Buy	Maintains	$22 → $21	+16.09%	Oct 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

86.39M

from 54.55M

58.38%

from 54.55M

Revenue Next Year

56.97M

from 86.39M

-34.06%

from 86.39M

EPS This Year

-3.21

from -2.88

EPS Next Year

-3.38

from -3.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Nov 30, 2020	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026
Revenue	17.82M	29.75M	38.63M	76.99M	54.55M	86.39M	56.97M
Revenue Growth	-42.73%	66.95%	29.84%	99.31%	-29.15%	58.38%	-34.06%
EPS	-2.76	-2.73	-3.71	-2.65	-2.88	-3.21	-3.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	19

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	114.2M	99.8M
Avg	86.4M	57.0M
Low	69.0M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	109.4%	15.5%
Avg	58.4%	-34.1%
Low	26.5%	-

EPS Forecast

EPS	2025	2026
High	-3.09	-2.24
Avg	-3.21	-3.38
Low	-3.32	-4.37

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.